Literature DB >> 20153288

Size-dependent neurotoxicity of beta-amyloid oligomers.

Paulius Cizas1, Rima Budvytyte, Ramune Morkuniene, Radu Moldovan, Matteo Broccio, Mathias Lösche, Gediminas Niaura, Gintaras Valincius, Vilmante Borutaite.   

Abstract

The link between the size of soluble amyloid beta (Abeta) oligomers and their toxicity to rat cerebellar granule cells (CGC) was investigated. Variation in conditions during in vitro oligomerization of Abeta(1-42) resulted in peptide assemblies with different particle size as measured by atomic force microscopy and confirmed by dynamic light scattering and fluorescence correlation spectroscopy. Small oligomers of Abeta(1-42) with a mean particle z-height of 1-2 nm exhibited propensity to bind to phospholipid vesicles and they were the most toxic species that induced rapid neuronal necrosis at submicromolar concentrations whereas the bigger aggregates (z-height above 4-5 nm) did not bind vesicles and did not cause detectable neuronal death. A similar neurotoxic pattern was also observed in primary cultures of cortex neurons whereas Abeta(1-42) oligomers, monomers and fibrils were non-toxic to glial cells in CGC cultures or macrophage J774 cells. However, both oligomeric forms of Abeta(1-42) induced reduction of neuronal cell densities in the CGC cultures. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153288      PMCID: PMC2853175          DOI: 10.1016/j.abb.2010.02.001

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  31 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

2.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

3.  Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42.

Authors:  Yun-Ru Chen; Charles G Glabe
Journal:  J Biol Chem       Date:  2006-06-29       Impact factor: 5.157

4.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.

Authors:  Stefan Barghorn; Volker Nimmrich; Andreas Striebinger; Carsten Krantz; Patrick Keller; Bodo Janson; Michael Bahr; Martin Schmidt; Robert S Bitner; John Harlan; Eve Barlow; Ulrich Ebert; Heinz Hillen
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

6.  Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.

Authors:  James P Cleary; Dominic M Walsh; Jacki J Hofmeister; Ganesh M Shankar; Michael A Kuskowski; Dennis J Selkoe; Karen H Ashe
Journal:  Nat Neurosci       Date:  2004-12-19       Impact factor: 24.884

7.  Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.

Authors:  Ganesh M Shankar; Shaomin Li; Tapan H Mehta; Amaya Garcia-Munoz; Nina E Shepardson; Imelda Smith; Francesca M Brett; Michael A Farrell; Michael J Rowan; Cynthia A Lemere; Ciaran M Regan; Dominic M Walsh; Bernardo L Sabatini; Dennis J Selkoe
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

Review 8.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.

Authors:  Igor Klyubin; Vicki Betts; Alfred T Welzel; Kaj Blennow; Henrik Zetterberg; Anders Wallin; Cynthia A Lemere; William K Cullen; Ying Peng; Thomas Wisniewski; Dennis J Selkoe; Roger Anwyl; Dominic M Walsh; Michael J Rowan
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

View more
  46 in total

1.  Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.

Authors:  Ali Reza A Ladiwala; Jeffrey Litt; Ravi S Kane; Darryl S Aucoin; Steven O Smith; Swarnim Ranjan; Judianne Davis; William E Van Nostrand; Peter M Tessier
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

Review 2.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

3.  Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.

Authors:  Robin Altman; Sonny Ly; Silvia Hilt; Jitka Petrlova; Izumi Maezawa; Tamás Kálai; Kálmán Hideg; Lee-Way Jin; Ted A Laurence; John C Voss
Journal:  Biochim Biophys Acta       Date:  2015-09-14

4.  Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol.

Authors:  Saurabh Trikha; Aleksandar M Jeremic
Journal:  J Biol Chem       Date:  2011-08-24       Impact factor: 5.157

5.  Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment.

Authors:  Isabel Morgado; Karin Wieligmann; Magdalena Bereza; Raik Rönicke; Katrin Meinhardt; Karthikeyan Annamalai; Monika Baumann; Jessica Wacker; Peter Hortschansky; Miroslav Malešević; Christoph Parthier; Christian Mawrin; Cordelia Schiene-Fischer; Klaus G Reymann; Milton T Stubbs; Jochen Balbach; Matthias Görlach; Uwe Horn; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-18       Impact factor: 11.205

6.  Protective action of NADPH oxidase inhibitors and role of NADPH oxidase in pathogenesis of colon inflammation in mice.

Authors:  Rima Ramonaite; Jurgita Skieceviciene; Simonas Juzenas; Violeta Salteniene; Juozas Kupcinskas; Paulius Matusevicius; Vilmante Borutaite; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

7.  Binding to the lipid monolayer induces conformational transition in Aβ monomer.

Authors:  Seongwon Kim; Dmitri K Klimov
Journal:  J Mol Model       Date:  2012-09-29       Impact factor: 1.810

8.  Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.

Authors:  Katherine Lynn Youmans; Steffi Leung; Juan Zhang; Erika Maus; Kathleen Baysac; Guojun Bu; Robert Vassar; Chunjiang Yu; Mary Jo LaDu
Journal:  J Neurosci Methods       Date:  2011-01-08       Impact factor: 2.390

Review 9.  Potential mechanisms and implications for the formation of tau oligomeric strains.

Authors:  Julia E Gerson; Amrit Mudher; Rakez Kayed
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

10.  Distinct Neurotoxic Effects of Extracellular Tau Species in Primary Neuronal-Glial Cultures.

Authors:  Katryna Pampuscenko; Ramune Morkuniene; Lukas Krasauskas; Vytautas Smirnovas; Taisuke Tomita; Vilmante Borutaite
Journal:  Mol Neurobiol       Date:  2020-10-01       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.